it is used only topically due to cardiotoxicity it was synthesized by william prusoff in the late 1950s initially developed as an anticancer drug idoxuridine became the first antiviral agent in 1962 idoxuridine is mainly used topically to treat herpes simplex keratitis epithelial lesions especially initial attacks presenting with a dendritic ulcer are most responsive to therapy while infection with stromal involvement are less responsive idoxuridine is ineffective against herpes simplex virus type 2 and varicella zoster common side effects of the eye drops include irritation blurred vision and photophobia corneal clouding and damage of the corneal epithelium may also occur idoxuridine is available as either a 0 5 ophthalmic ointment or as a 0 1 ophthalmic solution the dosage of the ointment is every 4 hours during day and once before bedtime the dosage of the solution is 1 drop in the conjunctival sac hourly during the day and every 2 hours during the night until definitive improvement then 1 drop every 2 hours during the day and every 4 hours during the night therapy is continued for 3 4 days after healing is complete as demonstrated by fluorescein staining